Your browser doesn't support javascript.
loading
A highly predictive autoantibody-based biomarker panel for prognosis in early-stage NSCLC with potential therapeutic implications.
Patel, Akshay J; Tan, Ti-Myen; Richter, Alex G; Naidu, Babu; Blackburn, Jonathan M; Middleton, Gary W.
Afiliação
  • Patel AJ; Institute of Immunology and Immunotherapy (III), College of Medical and Dental Sciences, University of Birmingham, Birmingham, England, UK.
  • Tan TM; Sengenics Corporation, Level M, Plaza Zurich, Damansara Heights, Kuala Lumpur, 50490, Malaysia.
  • Richter AG; Institute of Immunology and Immunotherapy (III), College of Medical and Dental Sciences, University of Birmingham, Birmingham, England, UK.
  • Naidu B; Institute of Inflammation and Ageing (IIA), College of Medical Sciences, University of Birmingham, Birmingham, England, UK.
  • Blackburn JM; Sengenics Corporation, Level M, Plaza Zurich, Damansara Heights, Kuala Lumpur, 50490, Malaysia.
  • Middleton GW; Institute of Infectious Disease and Molecular Medicine; Department of Integrative Biomedical Sciences; Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Br J Cancer ; 126(2): 238-246, 2022 02.
Article em En | MEDLINE | ID: mdl-34728792

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Análise Serial de Proteínas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Análise Serial de Proteínas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido